DCs, especially the Batf3-dependent sub-family characterized by CD8α and/or CD103 expression, are essential for anti-cancer immune responses (Diamond et al., 2011; Fuertes et al., 2011; Hildner et al., 2008). This evidence concerns the gene BATF3 and cancer.